nodes	percent_of_prediction	percent_of_DWPC	metapath
Cycloserine—Neurological symptom—Pamidronate—osteoporosis	0.0738	0.0738	CcSEcCtD
Cycloserine—Coma—Calcium Acetate—osteoporosis	0.0477	0.0477	CcSEcCtD
Cycloserine—Osteoarthritis—Etidronic acid—osteoporosis	0.0249	0.0249	CcSEcCtD
Cycloserine—Osteoarthritis—Ibandronate—osteoporosis	0.0206	0.0206	CcSEcCtD
Cycloserine—Psychotic disorder—Calcitriol—osteoporosis	0.0197	0.0197	CcSEcCtD
Cycloserine—Confusional state—Calcium Acetate—osteoporosis	0.0188	0.0188	CcSEcCtD
Cycloserine—Cardiac failure congestive—Pamidronate—osteoporosis	0.0178	0.0178	CcSEcCtD
Cycloserine—Osteoarthritis—Risedronate—osteoporosis	0.017	0.017	CcSEcCtD
Cycloserine—Paraesthesia—Calcium Acetate—osteoporosis	0.0167	0.0167	CcSEcCtD
Cycloserine—Dysarthria—Estradiol—osteoporosis	0.0166	0.0166	CcSEcCtD
Cycloserine—Osteoarthritis—Pamidronate—osteoporosis	0.0162	0.0162	CcSEcCtD
Cycloserine—Disorientation—Conjugated Estrogens—osteoporosis	0.0159	0.0159	CcSEcCtD
Cycloserine—Psychotic disorder—Pamidronate—osteoporosis	0.0158	0.0158	CcSEcCtD
Cycloserine—Cardiac failure congestive—Conjugated Estrogens—osteoporosis	0.0157	0.0157	CcSEcCtD
Cycloserine—Drowsiness—Calcitriol—osteoporosis	0.0156	0.0156	CcSEcCtD
Cycloserine—Feeling abnormal—Calcium Acetate—osteoporosis	0.0154	0.0154	CcSEcCtD
Cycloserine—Osteoarthritis—Zoledronate—osteoporosis	0.0148	0.0148	CcSEcCtD
Cycloserine—Hypersensitivity—Calcium Acetate—osteoporosis	0.0137	0.0137	CcSEcCtD
Cycloserine—Confusional state—Etidronic acid—osteoporosis	0.0123	0.0123	CcSEcCtD
Cycloserine—Vertigo—Estropipate—osteoporosis	0.0117	0.0117	CcSEcCtD
Cycloserine—Vertigo—Alendronate—osteoporosis	0.0115	0.0115	CcSEcCtD
Cycloserine—Osteoarthritis—Estradiol—osteoporosis	0.0114	0.0114	CcSEcCtD
Cycloserine—Vertigo—Raloxifene—osteoporosis	0.0113	0.0113	CcSEcCtD
Cycloserine—Vertigo—Ibandronate—osteoporosis	0.0112	0.0112	CcSEcCtD
Cycloserine—Paraesthesia—Etidronic acid—osteoporosis	0.011	0.011	CcSEcCtD
Cycloserine—Convulsion—Calcitriol—osteoporosis	0.0105	0.0105	CcSEcCtD
Cycloserine—Feeling abnormal—Etidronic acid—osteoporosis	0.0101	0.0101	CcSEcCtD
Cycloserine—Paraesthesia—Estropipate—osteoporosis	0.0095	0.0095	CcSEcCtD
Cycloserine—Somnolence—Estropipate—osteoporosis	0.00941	0.00941	CcSEcCtD
Cycloserine—Vertigo—Risedronate—osteoporosis	0.00921	0.00921	CcSEcCtD
Cycloserine—Paraesthesia—Ibandronate—osteoporosis	0.00911	0.00911	CcSEcCtD
Cycloserine—Hypersensitivity—Etidronic acid—osteoporosis	0.00901	0.00901	CcSEcCtD
Cycloserine—Somnolence—Calcitriol—osteoporosis	0.00883	0.00883	CcSEcCtD
Cycloserine—Feeling abnormal—Alendronate—osteoporosis	0.00859	0.00859	CcSEcCtD
Cycloserine—Convulsion—Pamidronate—osteoporosis	0.00844	0.00844	CcSEcCtD
Cycloserine—Feeling abnormal—Ibandronate—osteoporosis	0.00836	0.00836	CcSEcCtD
Cycloserine—Tremor—Zoledronate—osteoporosis	0.00834	0.00834	CcSEcCtD
Cycloserine—Confusional state—Pamidronate—osteoporosis	0.00802	0.00802	CcSEcCtD
Cycloserine—Vertigo—Zoledronate—osteoporosis	0.00799	0.00799	CcSEcCtD
Cycloserine—Hypersensitivity—Estropipate—osteoporosis	0.0078	0.0078	CcSEcCtD
Cycloserine—Rash—Etidronic acid—osteoporosis	0.00771	0.00771	CcSEcCtD
Cycloserine—Convulsion—Zoledronate—osteoporosis	0.00771	0.00771	CcSEcCtD
Cycloserine—Dermatitis—Etidronic acid—osteoporosis	0.00771	0.00771	CcSEcCtD
Cycloserine—Vertigo—Conjugated Estrogens—osteoporosis	0.0077	0.0077	CcSEcCtD
Cycloserine—Hypersensitivity—Alendronate—osteoporosis	0.00768	0.00768	CcSEcCtD
Cycloserine—Headache—Etidronic acid—osteoporosis	0.00766	0.00766	CcSEcCtD
Cycloserine—Paraesthesia—Risedronate—osteoporosis	0.00751	0.00751	CcSEcCtD
Cycloserine—Hypersensitivity—Ibandronate—osteoporosis	0.00748	0.00748	CcSEcCtD
Cycloserine—Convulsion—Conjugated Estrogens—osteoporosis	0.00742	0.00742	CcSEcCtD
Cycloserine—Confusional state—Zoledronate—osteoporosis	0.00732	0.00732	CcSEcCtD
Cycloserine—Hypersensitivity—Calcitriol—osteoporosis	0.00732	0.00732	CcSEcCtD
Cycloserine—Paraesthesia—Pamidronate—osteoporosis	0.00714	0.00714	CcSEcCtD
Cycloserine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00707	0.00707	CcSEcCtD
Cycloserine—Somnolence—Pamidronate—osteoporosis	0.00707	0.00707	CcSEcCtD
Cycloserine—Rash—Estropipate—osteoporosis	0.00667	0.00667	CcSEcCtD
Cycloserine—Dermatitis—Estropipate—osteoporosis	0.00667	0.00667	CcSEcCtD
Cycloserine—Headache—Estropipate—osteoporosis	0.00663	0.00663	CcSEcCtD
Cycloserine—Rash—Alendronate—osteoporosis	0.00657	0.00657	CcSEcCtD
Cycloserine—Dermatitis—Alendronate—osteoporosis	0.00657	0.00657	CcSEcCtD
Cycloserine—Feeling abnormal—Pamidronate—osteoporosis	0.00655	0.00655	CcSEcCtD
Cycloserine—Headache—Alendronate—osteoporosis	0.00653	0.00653	CcSEcCtD
Cycloserine—Paraesthesia—Zoledronate—osteoporosis	0.00652	0.00652	CcSEcCtD
Cycloserine—Rash—Raloxifene—osteoporosis	0.00646	0.00646	CcSEcCtD
Cycloserine—Dermatitis—Raloxifene—osteoporosis	0.00646	0.00646	CcSEcCtD
Cycloserine—Somnolence—Zoledronate—osteoporosis	0.00646	0.00646	CcSEcCtD
Cycloserine—Tremor—Estradiol—osteoporosis	0.00642	0.00642	CcSEcCtD
Cycloserine—Headache—Raloxifene—osteoporosis	0.00642	0.00642	CcSEcCtD
Cycloserine—Rash—Ibandronate—osteoporosis	0.0064	0.0064	CcSEcCtD
Cycloserine—Dermatitis—Ibandronate—osteoporosis	0.00639	0.00639	CcSEcCtD
Cycloserine—Headache—Ibandronate—osteoporosis	0.00636	0.00636	CcSEcCtD
Cycloserine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00632	0.00632	CcSEcCtD
Cycloserine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.00628	0.00628	CcSEcCtD
Cycloserine—Rash—Calcitriol—osteoporosis	0.00626	0.00626	CcSEcCtD
Cycloserine—Dermatitis—Calcitriol—osteoporosis	0.00626	0.00626	CcSEcCtD
Cycloserine—Headache—Calcitriol—osteoporosis	0.00622	0.00622	CcSEcCtD
Cycloserine—Somnolence—Conjugated Estrogens—osteoporosis	0.00622	0.00622	CcSEcCtD
Cycloserine—Hypersensitivity—Risedronate—osteoporosis	0.00616	0.00616	CcSEcCtD
Cycloserine—Vertigo—Estradiol—osteoporosis	0.00616	0.00616	CcSEcCtD
Cycloserine—Feeling abnormal—Zoledronate—osteoporosis	0.00598	0.00598	CcSEcCtD
Cycloserine—Hypersensitivity—Pamidronate—osteoporosis	0.00586	0.00586	CcSEcCtD
Cycloserine—Confusional state—Estradiol—osteoporosis	0.00564	0.00564	CcSEcCtD
Cycloserine—Rash—Ethinyl Estradiol—osteoporosis	0.00541	0.00541	CcSEcCtD
Cycloserine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.0054	0.0054	CcSEcCtD
Cycloserine—Headache—Ethinyl Estradiol—osteoporosis	0.00537	0.00537	CcSEcCtD
Cycloserine—Hypersensitivity—Zoledronate—osteoporosis	0.00535	0.00535	CcSEcCtD
Cycloserine—Rash—Risedronate—osteoporosis	0.00527	0.00527	CcSEcCtD
Cycloserine—Dermatitis—Risedronate—osteoporosis	0.00527	0.00527	CcSEcCtD
Cycloserine—Headache—Risedronate—osteoporosis	0.00524	0.00524	CcSEcCtD
Cycloserine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00515	0.00515	CcSEcCtD
Cycloserine—Paraesthesia—Estradiol—osteoporosis	0.00503	0.00503	CcSEcCtD
Cycloserine—Rash—Pamidronate—osteoporosis	0.00501	0.00501	CcSEcCtD
Cycloserine—Dermatitis—Pamidronate—osteoporosis	0.00501	0.00501	CcSEcCtD
Cycloserine—Headache—Pamidronate—osteoporosis	0.00498	0.00498	CcSEcCtD
Cycloserine—Somnolence—Estradiol—osteoporosis	0.00498	0.00498	CcSEcCtD
Cycloserine—Feeling abnormal—Estradiol—osteoporosis	0.00461	0.00461	CcSEcCtD
Cycloserine—Rash—Zoledronate—osteoporosis	0.00458	0.00458	CcSEcCtD
Cycloserine—Dermatitis—Zoledronate—osteoporosis	0.00457	0.00457	CcSEcCtD
Cycloserine—Headache—Zoledronate—osteoporosis	0.00455	0.00455	CcSEcCtD
Cycloserine—Rash—Conjugated Estrogens—osteoporosis	0.00441	0.00441	CcSEcCtD
Cycloserine—Dermatitis—Conjugated Estrogens—osteoporosis	0.00441	0.00441	CcSEcCtD
Cycloserine—Headache—Conjugated Estrogens—osteoporosis	0.00438	0.00438	CcSEcCtD
Cycloserine—Hypersensitivity—Estradiol—osteoporosis	0.00412	0.00412	CcSEcCtD
Cycloserine—Rash—Estradiol—osteoporosis	0.00353	0.00353	CcSEcCtD
Cycloserine—Dermatitis—Estradiol—osteoporosis	0.00353	0.00353	CcSEcCtD
Cycloserine—Headache—Estradiol—osteoporosis	0.00351	0.00351	CcSEcCtD
